Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules
In tick-borne encephalitis (TBE)-endemic regions, long-term vaccination programs are efficient in preventing the disease. A booster dose of a polygeline-free inactivated TBE vaccine (Encepur Adults, GSK), administered approximately 3 years post-primary vaccination according to 1 of 3 licensed vaccin...
Saved in:
Main Authors: | Marco Costantini (Author), Andrea Callegaro (Author), Jiří Beran (Author), Valérie Berlaimont (Author), Ilaria Galgani (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Response letter: "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules"
by: Marco Costantini, et al.
Published: (2020) -
Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules
by: Ilaria Galgani, et al.
Published: (2017) -
Letter to the editor: Readers response to "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules"
by: Farid Khan, et al.
Published: (2020) -
Tick-borne encephalitis in children
by: A. P. Pomogaeva, et al.
Published: (2019) -
Tick-borne encephalitis and differential diagnosis
by: Patrycja Ochman-Pasierbek, et al.
Published: (2024)